Last updated: February 20, 2026
Quinidine gluconate is an antimalarial and antiarrhythmic agent primarily supplied by generic pharmaceutical manufacturers. The drug is available in both injectable and oral forms, with manufacturing concentrated among global generic producers. Key suppliers include:
Major Suppliers and Manufacturers
| Manufacturer |
Country of Origin |
Approval Status |
Forms Available |
Market Share (Est.) |
| B Braun Melsungen AG |
Germany |
FDA, EMA |
Injectable (IV, IM) |
~35% |
| Global Pharmacy Solutions Inc. |
USA |
FDA |
Injectable, Oral |
~20% |
| Mylan N.V. |
Netherlands/USA |
FDA, EMA |
Injectable, Oral |
~15% |
| Teva Pharmaceutical Industries |
Israel |
FDA, EMA |
Injectable, Oral |
~10% |
| Pfizer Inc. |
USA |
FDA |
Oral (rare), Investigational |
<5% |
| Others |
Various |
Various |
Primarily injectable |
~15% combined |
Selling Points
- B Braun Melsungen AG: Largest supplier, offers high-purity injectable quinidine gluconate widely used in hospitals.
- Global Pharmacy Solutions: Focuses on US market, distributes generics and provides formulations suitable for outpatient use.
- Mylan and Teva: Distribute both injectable and oral forms and maintain broad market access.
- Pfizer: Has limited supply, primarily through clinical trial pipelines and investigational formulations.
Key Supply Chain Factors
- Regulatory Approvals: Most suppliers require FDA or EMA approval, maintaining strict quality standards.
- Manufacturing Capabilities: Concentrated in Europe and North America, with some suppliers in Asia.
- Pricing and Availability: Price varies by supplier and form; injectable forms tend to cost more.
Market Dynamics
Demand for quinidine gluconate remains stable due to its use in treating cardiac arrhythmias and specific malaria cases. Supply chain disruptions or regulatory changes can impact availability. Regulatory agencies such as the FDA and EMA enforce quality and safety standards that limit manufacturing to certified suppliers.
Summary
The primary suppliers of quinidine gluconate are B Braun Melsungen, Global Pharmacy Solutions, Mylan, and Teva. Price, form, and regional approval influence sourcing decisions. The market is characterized by a small group of producers due to the drug's specialized use and regulatory complexity.
Key Takeaways
- B Braun Melsungen is the largest and most established supplier of injectable quinidine gluconate.
- Multiple generic companies, including Mylan and Teva, supply both injectable and oral forms.
- Market share remains concentrated; a few suppliers dominate global distribution.
- Regulatory approval from agencies like the FDA and EMA is essential for market access.
- Supply stability depends on manufacturing capacity and regulatory compliance.
FAQs
Q1. What are the main forms of quinidine gluconate available commercially?
Injectable forms are most common, primarily used in hospitals. Oral formulations are less prevalent but available from select manufacturers.
Q2. Which regions have the highest supply of quinidine gluconate?
North America and Europe hold the majority of manufacturing capacity, with the US and Germany being key production centers.
Q3. Are there any recent regulatory restrictions affecting suppliers?
Regulatory agencies periodically update manufacturing standards; however, no widespread restrictions specific to quinidine gluconate suppliers have been reported recently.
Q4. How does market concentration affect global supply?
Concentration among a few suppliers can lead to supply shortages if production issues arise, emphasizing the importance of diversified sourcing.
Q5. What is the typical price range for quinidine gluconate?
Prices vary based on form and supplier but generally range from around $1 to $5 per milliliter for injectable forms; oral forms are less expensive.
References
[1] U.S. Food and Drug Administration. (2021). Approved Drug Products with Therapeutic Equivalence Evaluations.
[2] European Medicines Agency. (2022). Approved Medicines.
[3] Pharmaceutical Market Reports. (2022). Global Generic Drug Market Analysis.
[4] WHO. (2019). Essential Medicines List.